The information of driver oncogenes and PD-L1 expression is important for determining the prognosis of and treatment strategy for lung cancer patients; however, this information was unknown in many patients in our cohort, and therefore we could not include these factors in the analysis. This evidence concerns the gene CD274 and lung cancer.